Literature DB >> 31601719

The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines.

José A Caminero1,2, Alberto L García-Basteiro3,4, Adrián Rendon5, Alberto Piubello2,6, Emanuele Pontali7, Giovanni Battista Migliori8.   

Abstract

Entities:  

Year:  2019        PMID： 31601719     DOI： 10.1183/13993003.01272-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.

Authors:  Martha L van der Walt; Karen Shean; Piet Becker; Karen H Keddy; Joey Lancaster
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

2.  Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing.

Authors:  Navisha Dookie; Nesri Padayatchi; Richard J Lessells; Cherise L Naicker; Sunitha Chotoo; Kogieleum Naidoo
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

3.  Susceptibility pattern of Mycobacterium tuberculosis over a period of five years at Indus Hospital and Health Network, Karachi, Pakistan.

Authors:  Nazia Khursheed; Sunil Asif; Safia Bano; Maria Mushtaq Ali; Fareeha Adnan
Journal:  Pak J Med Sci       Date:  2022-01       Impact factor: 1.088

Review 4.  MDR Tuberculosis Treatment.

Authors:  Juan Espinosa-Pereiro; Adrian Sánchez-Montalvá; Maria Luisa Aznar; Maria Espiau
Journal:  Medicina (Kaunas)       Date:  2022-01-26       Impact factor: 2.430

5.  Prevalence of primary anti-tuberculosis drug resistance at the tertiary center in Saudi Arabia and associated risk factors.

Authors:  Mohammed S Al-Shahrani; Majed I Hakami; Mahmoud A Younis; Hanan A Fan; Mohammed A Jeraiby; Yasser Alraey
Journal:  Saudi Med J       Date:  2021-07       Impact factor: 1.422

6.  Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients.

Authors:  Zenawi Zeramariam Araia; Araia Berhane Mesfin; Amanuel Hadgu Mebrahtu; Adiam Ghebreyohanns Tewelde; Asmerom Tesfagiorgis Tewelde; Solyana Ngusbrhan Kidane
Journal:  Patient Relat Outcome Meas       Date:  2021-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.